Search Login Register

Latent Tuberculosis Summary

Description: The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test.

Also Known As: Infection, Latent Tuberculosis; Infections, Latent Tuberculosis; Latent Tuberculoses; Latent Tuberculosis Infections; Tuberculoses, Latent Show All >>

Networked: 1126 relevant articles (56 outcomes, 107 trials/studies) for this Disease

Key Drugs and Agents for Latent Tuberculosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Isoniazid (Ftivazide) : 17 outcomes 21 studies in 174 results : FDA 49 Generic
  2. Tuberculin (PPD) : 13 outcomes 35 studies in 380 results : IBA
  3. Interferon-gamma (Interferon, gamma) : 12 outcomes 12 studies in 230 results : IBA
  4. Antigens : 6 outcomes 4 studies in 61 results : IBA
  5. Interferons : 4 outcomes 4 studies in 68 results : IBA
  6. Rifampin (Rifampicin) : 3 outcomes 13 studies in 85 results : FDA 13 Generic
  7. Gold : 2 outcomes 16 studies in 141 results : IBA
  8. Pyrazinamide : 2 outcomes 5 studies in 45 results : FDA 3 Generic
  9. rifapentine (Priftin) : 2 outcomes 5 studies in 19 results : FDA 1
  10. Carbon Monoxide : 2 outcomes 1 study in 16 results : IBA
Show All >>

Diseases Related to Latent Tuberculosis

  1. Tuberculosis (Tuberculoses)
  2. Infection
  3. Latent Tuberculosis
  4. Psoriasis (Pustulosis Palmaris et Plantaris)
  5. Rheumatic Diseases (Rheumatism)
Show All >>

Key Therapies for Latent Tuberculosis

Efficacy Chart >>
  1. Chemoprevention : 2 outcomes 4 studies in 35 results
  2. Drug Therapy (Chemotherapy) : 1 outcome 5 studies in 20 results
  3. Aftercare (After-Treatment) : 1 outcome in 7 results
  4. Renal Dialysis (Hemodialysis) : 4 studies in 20 results
  5. Transplants (Transplant) : 3 studies in 19 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.